GSK plc (NYSE: GSK) executive trades 38,000 shares on London market
Rhea-AI Filing Summary
GSK plc reported that Regis Simard, President, Global Supply Chain, carried out a market transaction in the company’s shares. Simard sold 38,000 Ordinary Shares of 31 ¼ pence each at a price of £20.3800 per share.
The sale took place on 29 July 2026 on the London Stock Exchange (XLON). The disclosure identifies Simard as a PDMR (person discharging managerial responsibilities) and classifies this as an initial notification of the transaction.
Positive
- None.
Negative
- None.
Filing Explained
GSK’s Form 6-K, an interim report for material information published by a foreign private issuer, records Regis Simard’s sale of 38,000 ordinary shares on July 29, 2026; the filing does not disclose a Rule 10b5-1 trading plan for the sale.
Key Figures
Shares sold: 38,000 shares
Sale price: £20.3800 per share
Nominal value: 31 ¼ pence each
+1 more
4 metrics
Shares sold
38,000 shares
Sale of GSK Ordinary Shares by Regis Simard
Sale price
£20.3800 per share
Price for the 38,000 Ordinary Shares sold
Nominal value
31 ¼ pence each
Nominal value of GSK Ordinary Shares
Transaction date
2026-07-29
Date of the share sale on London Stock Exchange
Key Terms
PDMR, Ordinary Shares, ISIN, London Stock Exchange (XLON)
4 terms
PDMR financial
"Details of PDMR/person closely associated with them ('PCA')"
A PDMR (person discharging managerial responsibilities) is an individual who can shape a company’s strategy or finances—typically senior executives, board members, or close advisors with decision-making authority. Investors care because PDMRs often hold material, non‑public information and their buying or selling of shares must be reported; monitoring those disclosures is like watching a ship’s captain to read the likely course and spot possible insider risk.
ISIN financial
"ISIN: GB00BN7SWP63"
A 12-character International Securities Identification Number (ISIN) is a unique code that acts like a passport for a specific stock, bond or other tradable security so it can be identified worldwide. Investors and systems use it to ensure they are buying, selling and tracking the exact same instrument across exchanges and data feeds, which prevents costly mix-ups and makes portfolio reporting, settlement and regulatory checks simpler and more reliable.
London Stock Exchange (XLON) financial
"Place of the transaction | London Stock Exchange (XLON)"
AI-generated analysis. How Rhea-AI works. Not financial advice.
FAQ
Who is Regis Simard in relation to GSK (GSK)?
Regis Simard is identified as President, Global Supply Chain at GSK and is treated as a PDMR. As a senior executive, transactions in GSK shares by Simard are subject to disclosure requirements and reported through regulatory announcements.
What type of GSK (GSK) security did Regis Simard sell?
The transaction involved Ordinary Shares of 31 ¼ pence each in GSK. The filing identifies them as Ordinary Shares with ISIN GB00BN7SWP63, representing the company’s standard equity listed on the London Stock Exchange.
Is this GSK (GSK) transaction filing an initial notification or an amendment?
The filing classifies the disclosure as an initial notification of the transaction by Regis Simard. It is not marked as an amendment and therefore represents the first regulatory report of this particular share sale.